GlobeNewswire by notified

Havila Shipping ASA: Fourt quarter 2022 report/2022 Preliminary report


The market for the company’s vessels has been variable in the fourth quarter. The company has been exposed to a limited extent in the spot market. Income and profit are affected to a significant extent by the sale of vessels, and reversed write-downs of vessels. Reversed write-downs result from increased income estimates and also result in an increased debt value.

Agreement with lenders entered into in 2020 clarifies the company’s obligations towards the lenders for the period until 2024. Five vessels that have been in lay-up, of which 3 AHTS and 2 PSV, have been sold. Of these, 3 vessels were delivered to new owners in the second quarter, one vessel was delivered in the third quarter and one vessel was delivered in the fourth quarter.
Another vessel has been agreed sold, and was delivered to the new owner in January 2023. The vessel is per 31/12/22 classified as assets held for sale. After the maximum reversal of historical impairment charges, the book amount is lower than the sales value. The debt is recognized at fair value, which is approximately equal to the sales value. As a result of the debt associated with this vessel being valued at fair value as of 31/12/22, while the book value of the vessel is limited to the original depreciation plan, the group will have negative equity at the end of 2022. The group’s equity became positive again when a significant gain on sale of assets is booked upon delivery of the vessel in January 2023.

Havila Shipping ASA achieved an operating income before depreciation of NOK 50.4 million in Q4 2022, compared with NOK 36.4 million in Q4 2021.

  • Total operating income was NOK 171.9 million in Q4 2022, compared with NOK 144.9 million in Q4 2021.
  • The group had as of 31/12/22 17 vessels operated from Fosnavåg, six for external owners.
  • The fleet utilization in Q4 2022 was 89 %.

Result for 4 quarter 2022

  • Total operating income amounted to NOK 171.9 million, whereof NOK 22.1 million is gain on sale of fixed assets (NOK 144.9 million).
  • Total operating expenses were NOK 121.5 million (NOK 108.5 million). 
  • Operating profit before depreciation was NOK 50.4 million (NOK 36.4 million).
  • Depreciation was NOK 37.7 million (NOK 48.3 million).
  • Reversal of impairment charge of fixed assets was NOK 226.0 million (NOK 260.8 million).
  • Net financial items were NOK - 323.0 million (NOK - 11.5 million), whereof unrealized agio gain was NOK 72.6 million (unrealized agio loss NOK 3.7 million), and value adjustment of debt was NOK - 388.7 million (NOK - 13.4 million).
  • The profit before tax was NOK - 80.5 million (NOK 65.7 million).

Result 2022

  • Total operating income amounted to NOK 824.4 million (NOK 545.5 million).
  • Total operating expenses were NOK 427.0 million whereof NOK - 21.2 million is reimbursement of costs from the banks for the vessels in lay-up. This reimbursement is divided between NOK 7.1 million on crew expenses, NOK 9.0 million on vessel expenses and NOK 4.7 million on other operating expenses. (NOK 395.7 million whereof NOK - 24.5 million is change of loss on trade receivables). Ordinary operating expenses amounts to NOK 448.3 million (NOK 409.8 million).
  • The operating profit before depreciation was NOK 397.4 million (NOK 160.1 million).
  • Depreciation was NOK 183.7 million (NOK 203.6 million).
  • Reversal of impairment charge of fixed assets was NOK 226.0 million (NOK 235.3 million).
  • Net financial items were NOK - 545.1 million (NOK - 124.7 million), whereof unrealized agio loss was NOK 76.6 million (unrealized agio loss NOK 21.5 million) and value adjustment of debt NOK - 456.5 million (NOK - 102.1 million).
  • The profit before tax was NOK - 111.8 million (NOK 65.8 million).

Balance and liquidity per 31/12/22
Total current assets amounted to NOK 698.3 million on 31/12/22, whereof bank deposits were NOK 147.4 million (whereof NOK 70.8 million restricted cash related to withholding tax, interest and instalment payments and deposit in connection with sale of vessel). On 31/12/21, total current assets amounted to NOK 245.2 million, whereof bank deposits amounted to NOK 100.9 million (of this NOK 5.4 million restricted cash related to withholding tax).

Net cash flow from operations was per 31/12/22 NOK 229.7 million (NOK 126.5 million). Cash flow from investing activities was NOK - 35.2 million (NOK - 34.2 million). Payment of loan instalments and lease liabilities constituted a net change from financing activities of NOK - 144.9 million (NOK - 98.2 million).

As of 31/12/22, the book value of the fleet is NOK 1,140 million.

Total long-term loan debt recognized in the balance sheet was per 31/12/22 NOK 1,677.7 million, of which interest-bearing debt amounts to NOK 1,578.6 million and non-interest-bearing debt NOK 99.1 million. As of 31/12/22, nominal value of interest-bearing debt was NOK 1,781.0 million, and nominal value of non-interest-bearing debt was NOK 1,657.1 million. Of nominal interest-bearing debt 29.5 % are loans in USD, while the remaining loans are in NOK. Secured debt are classified as long-term debt, except from known instalments which is classified as short-term debt.

Havila Shipping ASA operates today 17 vessels,

11 PSV
- Four owned externally
- One owned 50% and not consolidated
3 Subsea
- One owned externally
- One hired out on bareboat contract
1 RRV (bareboat)


Havila Shipping ASA had per 31/12/22 382 employees on the company’s vessels and 15 employees in the administration.

CEO Njål Sævik, +47 909 35 722
CFO Arne Johan Dale, +47 909 87 706

This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act


To view this piece of content from, please give your consent at the top of this page.
To view this piece of content from, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Junshi Biosciences Announces Establishment of Joint Venture with Rxilient Biotech to Jointly Develop and Commercialize Toripalimab in Southeast Asia29.3.2023 05:39:38 CEST | Press release

-- The two parties will collaborate to develop and commercialize toripalimab in 9 Southeast Asian countries through a joint venture company, Excellmab -- Excellmab will be responsible for the development, medical affairs, production of finished products, and commercialization of toripalimab within the cooperation territory. The profits available for distribution by Excellmab will be distributed in proportion to the respective shareholdings of the parties -- Using the Excellmab platform, the two parties also plan to collaborate extensively to introduce more high-quality innovative drugs into Southeast Asian markets to achieve joint and long-term development -- According to the progress of toripalimab’s R&D and other projects, Junshi Biosciences may receive a milestone payment of up to approximately US$4.52 million, plus a certain percentage of royalties on net sales SHANGHAI, China and SINGAPORE, March 28, 2023 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Bioscience

Aduro Clean Technologies Increases Size of Private Placement to $4 Million29.3.2023 02:12:40 CEST | Press release

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES SARNIA, Ontario, March 28, 2023 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (CSE: ACT) (OTCQB: ACTHF) (FSE: 9D50), a Canadian developer of patented water-based technologies to chemically recycle plastics, and to transform heavy crude and renewable oils into feedstocks and higher-value fuels, is pleased to announce that, further to its news release dated March 8, 2023, it has increased the size of its non-brokered private placement of units (the “Units”) at $0.93 per Unit for gross proceeds of a minimum of $1,999,965 and up to a maximum of $4,000,000 (the “LIFE Offering”). Each Unit will consist of one (1) common share in the capital of the Company (each, a “Common Share”) and one-half (1/2) of one Common Share purchase warrant (each whole warrant, a “Warrant”). Each Warrant will be exercisable into one (1) Common Share (each, a “Warrant Share”) at a price o

ClearPoint Neuro Announces Exclusive Multi-Year Licensing Agreement with UCSF for Innovative Intra-Cerebral Cellular Delivery Platform28.3.2023 22:05:00 CEST | Press release

SOLANA BEACH, Calif., March 28, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced an exclusive multi-year licensing agreement of intellectual property from UC San Francisco (UCSF) through its Innovation Ventures group to develop and commercialize a radially branching cellular delivery device for use both in the Operating Room under fluoroscopy/CT guidance and under MRI guidance. “This invention will help clinicians guide the delivery of biologic therapies — from stem cell transplants to gene therapy vectors — to specific locations in the human brain with real-time image guidance,” said Dr. Daniel Lim, MD, PhD, Professor of Neurological Surgery at UCSF. “By helping surgeons tailor biologic delivery to individual patient anatomy and specific diseases, I hope that this invention can contribute importantly to the successful treatment of neurological disor

Development of the Annual General Meeting of the BANK of Greenland28.3.2023 22:03:19 CEST | Press release

Minutes of General Meeting To Nasdaq OMX Copenhagen 28 March 2022 Company announcement no. 05/2023 Development of the Annual General Meeting of the BANK of Greenland Today, the BANK of Greenland held its Annual General Meeting in accordance with the Articles of Association and the previously published notice convening the meeting. The Annual General Meeting was attended by shareholders representing 1,049,468 votes, of which 612,498 votes were given by proxy to the Board of Directors, 62,821 votes were covered by instructions to holders of power of attorney and 115,455 votes of correspondance. The Board of Directors' Report on the Bank's activities during the past year The Chairman of the Board of Directors Gunnar í Liða presented the Board of Directors' report on the Bank's activities during the past year. The report of the Board of Directors was noted. The Chairman's report can be viewed on the Bank's website at The minutes of the Annual General Meeting will also be pub

Forløb af ordinær generalforsamling i GrønlandsBANKEN28.3.2023 22:03:19 CEST | pressemeddelelse

Referat af Generalforsamling Til Nasdaq OMX Copenhagen 28. marts 2023 Selskabsmeddelelse nr. 05/2023 Forløb af ordinær generalforsamling i GrønlandsBANKEN GrønlandsBANKEN har i dag afholdt ordinær generalforsamling i henhold til vedtægterne og tidligere offentliggjort indkaldelse. Generalforsamlingen var repræsenteret med 1.049.468 stemmer, heraf var 612.498 stemmer givet som fuldmagt til bestyrelsen, 62.821 stemmer var givet som instruktionsfuldmagt, mens 115.455 var afgivet som brevstemme. Bestyrelsens beretning om bankens virksomhed i det forløbne år Bestyrelsesformand Gunnar í Liða aflagde bestyrelsens beretning om bankens virksomhed i det forløbne år. Bestyrelsens beretning blev taget til efterretning. Formandens beretning kan ses på bankens hjemmeside Generalforsamlingens protokollat vil senest 14 dage efter generalforsamlingens afholdelse ligeledes blive lagt på bankens hjemmeside. Godkendelse af årsrapporten for 2022, meddelelse om decharge for bestyrelse og direk